XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average exercise price     $ 32.95  
Stock options exercised by employees and directors 0 0 5,250 0
Number of shares of non-vested stock that vested 3,869 563 29,665 29,913
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Amortization of non-vested stock grants and performance-based awards $ 1,822,000 $ 1,683,000 $ 5,226,000 $ 4,603,000
Stock option plan, share based compensation, vesting period (in years)     3 years  
Aggregate fair value     $ 800  
Shares granted under performance plan     10,148  
Employees and Directors [Member] | Non-Vested Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares of non-vested stock issued     31,442  
Aggregate fair value     $ 3,900  
Employees and Directors [Member] | Non-Vested Shares [Member] | Minimum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option plan, share based compensation, vesting period (in years)     1 year  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value     $ 113.74  
Employees and Directors [Member] | Non-Vested Shares [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option plan, share based compensation, vesting period (in years)     5 years  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value     $ 149.73